Thiabendazole tablets bulk supplier for pharma manufacturers

Thiabendazole Tablets 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 500 mg

Reference Brands: Mintezol(US), Tebanic(EU)

Thiabendazole inhibits microtubule formation in parasites, disrupting nutrient absorption and leading to their death. It effectively treats intestinal worms like roundworms and hookworms, as well as skin infestations. Benefits include rapid symptom relief, parasite eradication, reduced transmission, and supporting gastrointestinal and dermatological health worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Thiabendazole tablets, marketed as Mintezol and Tebanic, are approved in the US by the FDA and in the EU via EMA for treating parasitic infections. Regulatory approval requires detailed dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper compliance supports timely approval, safe use, and global availability, effectively managing intestinal and skin parasitic infections worldwide, supporting health efforts against parasitic diseases.

Thiabendazole Tablets — third party manufacturing & bulk supply

Thiabendazole Tablets 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Thiabendazole Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Thiabendazole Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Thiabendazole Tablets →

Back to Listing

Frequently Asked Questions

Thiabendazole is used for treating parasitic infections such as strongyloidiasis, cutaneous larva migrans, and trichinosis. It works by inhibiting the parasite’s metabolic processes, ultimately destroying the worm. It has also been used as an antifungal agent in some cases.

Thiabendazole is made from the active ingredient thiabendazole, a synthetic benzimidazole derivative with broad-spectrum anthelmintic and antifungal activity.

A well-known trade name for Thiabendazole is Mintezol.

Mintezol was originally manufactured by Merck. Various generic manufacturers around the world also produce thiabendazole formulations.

The generic name is thiabendazole.

A commonly recognized brand name is Mintezol.

Thiabendazole is manufactured in multiple countries, including India, China, and several regions in Europe and the United States, where both branded and generic products are produced.